BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12600646)

  • 1. The role of Vif during HIV-1 infection: interaction with novel host cellular factors.
    Lake JA; Carr J; Feng F; Mundy L; Burrell C; Li P
    J Clin Virol; 2003 Feb; 26(2):143-52. PubMed ID: 12600646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.
    Hassaïne G; Courcoul M; Bessou G; Barthalay Y; Picard C; Olive D; Collette Y; Vigne R; Decroly E
    J Biol Chem; 2001 May; 276(20):16885-93. PubMed ID: 11278465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
    Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
    J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-dependent function of HIV-1 Vif for virus replication (Review).
    Inubushi R; Adachi A
    Int J Mol Med; 1999 May; 3(5):473-6. PubMed ID: 10202177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.
    Khan MA; Aberham C; Kao S; Akari H; Gorelick R; Bour S; Strebel K
    J Virol; 2001 Aug; 75(16):7252-65. PubMed ID: 11461998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
    J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure.
    Henzler T; Harmache A; Herrmann H; Spring H; Suzan M; Audoly G; Panek T; Bosch V
    J Gen Virol; 2001 Mar; 82(Pt 3):561-573. PubMed ID: 11172097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a host protein essential for assembly of immature HIV-1 capsids.
    Zimmerman C; Klein KC; Kiser PK; Singh AR; Firestein BL; Riba SC; Lingappa JR
    Nature; 2002 Jan; 415(6867):88-92. PubMed ID: 11780123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription.
    Dornadula G; Yang S; Pomerantz RJ; Zhang H
    J Virol; 2000 Mar; 74(6):2594-602. PubMed ID: 10684273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles.
    Douaisi M; Dussart S; Courcoul M; Bessou G; Lerner EC; Decroly E; Vigne R
    Biochem Biophys Res Commun; 2005 Apr; 329(3):917-24. PubMed ID: 15752743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent lack of trans-dominant negative effects of various vif mutants on the replication of HIV-1.
    Fujita M; Matsumoto S; Sakurai A; Doi N; Miyaura M; Yoshida A; Adachi A
    Microbes Infect; 2002 Oct; 4(12):1203-7. PubMed ID: 12467760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.
    Kao S; Khan MA; Miyagi E; Plishka R; Buckler-White A; Strebel K
    J Virol; 2003 Nov; 77(21):11398-407. PubMed ID: 14557625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cell-dependent replication of HIV-1 gag MA, CA, and NC mutants are independent of the functions of Vif and Vpu.
    Shimano R; Inubushi R; Adachi A
    Int J Mol Med; 1999 Jan; 3(1):91-4. PubMed ID: 9864392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.
    Zheng W; Ling L; Li Z; Wang H; Rui Y; Gao W; Wang S; Su X; Wei W; Yu XF
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28122978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.
    Nascimbeni M; Bouyac M; Rey F; Spire B; Clavel F
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1945-50. PubMed ID: 9714242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Vif protein of human immunodeficiency virus type 1 (HIV-1): enigmas and solutions.
    Baraz L; Kotler M
    Curr Med Chem; 2004 Jan; 11(2):221-31. PubMed ID: 14754418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of vif genes derived from various primate immunodeficiency viruses.
    Yamamoto Y; Saito Y; Iida S; Asano J; Sone S; Adachi A
    Virus Genes; 1997; 14(3):195-200. PubMed ID: 9311564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child.
    Alexander L; Aquino-DeJesus MJ; Chan M; Andiman WA
    J Virol; 2002 Oct; 76(20):10533-9. PubMed ID: 12239333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.